CHICAGO—A “cluster randomized controlled trial” of treatment for patients with advanced cancers found that the use of standardized geriatric assessments significantly increased the number and quality of discussions about age-related concerns in comparison with usual care and also resulted in higher scores of patient satisfaction—which the investigators regarded as paramount among therapy outcomes. (https://meetinglibrary.asco.org/record/159519/abstract)
In a media briefing about the study held at the 2018 Annual Meeting of the American Society of Clinical Oncology lead author Supriya Gupta Mohile MD MS, the Wehrheim professor of medicine and surgery and director of geriatric oncology at the University of Rochester, New York, emphasized the pivotal role of GA when treating older patients for their late-stage cancers. She talks with the Audio Journal of Oncology.
